IRIS Accounts Production v26.1.10.61 12821991 Board of Directors 1.4.25 31.3.26 31.3.26 21.7.26 0 false true false false true false Auditors Opinion iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 12821991 2025-03-31 12821991 2026-03-31 12821991 2025-04-01 2026-03-31 12821991 2024-03-31 12821991 2024-04-01 2025-03-31 12821991 2025-03-31 12821991 ns15:EnglandWales 2025-04-01 2026-03-31 12821991 ns14:PoundSterling 2025-04-01 2026-03-31 12821991 ns10:Director1 2025-04-01 2026-03-31 12821991 ns10:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 12821991 ns10:SmallEntities 2025-04-01 2026-03-31 12821991 ns10:Audited 2025-04-01 2026-03-31 12821991 ns10:SmallCompaniesRegimeForDirectorsReport 2025-04-01 2026-03-31 12821991 ns10:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 12821991 ns10:FullAccounts 2025-04-01 2026-03-31 12821991 ns5:CurrentFinancialInstruments 2026-03-31 12821991 ns5:CurrentFinancialInstruments 2025-03-31 12821991 ns5:ShareCapital 2026-03-31 12821991 ns5:ShareCapital 2025-03-31 12821991 ns5:RetainedEarningsAccumulatedLosses 2026-03-31 12821991 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 12821991 1 2025-04-01 2026-03-31 12821991 ns5:ComputerEquipment 2025-04-01 2026-03-31 12821991 ns5:ComputerEquipment 2025-03-31 12821991 ns5:ComputerEquipment 2026-03-31 12821991 ns5:ComputerEquipment 2025-03-31 12821991 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2026-03-31 12821991 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-03-31

REGISTERED NUMBER: 12821991 (England and Wales)

| FINANCIAL STATEMENTS |

| FOR THE YEAR ENDED 31 MARCH 2026 |

| FOR |

| LHM MEDICAL TECHNOLOGY (UK) LIMITED |

LHM MEDICAL TECHNOLOGY (UK) LIMITED (REGISTERED NUMBER: 12821991)

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

Page |

Balance Sheet | 1 |

Notes to the Financial Statements | 2 |

LHM MEDICAL TECHNOLOGY (UK) LIMITED (REGISTERED NUMBER: 12821991)

BALANCE SHEET

31 MARCH 2026

| 2026 |  | 2025

| (Unaudited)

| Notes | £ | £ |

FIXED ASSETS

Tangible assets | 4 | - |  | 1,568 |  |

CURRENT ASSETS

Stocks | 486 |  | 149,268 |  |

Debtors | 5 | 553 |  | 948 |  |

Cash at bank | 8,514 |  | 1,879 |  |

9,553 |  | 152,095 |  |

CREDITORS

Amounts falling due within one year | 6 | (1,168,523 | ) | (1,222,179 | ) |

NET CURRENT LIABILITIES | (1,158,970 | ) | (1,070,084 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | (1,158,970 | ) | (1,068,516 | ) |

CAPITAL AND RESERVES

Called up share capital | 1 |  | 1 |  |

Retained earnings | (1,158,971 | ) | (1,068,517 | ) |

(1,158,970 | ) | (1,068,516 | ) |

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 July 2026 and were signed on its behalf by:

C S A Chow - Director

LHM MEDICAL TECHNOLOGY (UK) LIMITED (REGISTERED NUMBER: 12821991)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

1. | STATUTORY INFORMATION

| LHM Medical Technology (UK) Limited is a private limited company, limited by shares, registered in England and Wales. The company's registered number is 12821991 and its registered office is Unit 2 Premier Park, Acheson Way, Trafford Park, Manchester, England, M17 1GA.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Critical accounting judgements and key sources of estimation uncertainty

| In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liability that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

| The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Computer equipment | - | 20% on cost

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

LHM MEDICAL TECHNOLOGY (UK) LIMITED (REGISTERED NUMBER: 12821991)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 MARCH 2026

2. | ACCOUNTING POLICIES - continued

| Financial instruments

| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' of FRS 102.

| Financial instruments are recongised when the company becomes party to the contractual provisions of the

| instrument.

| Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off recongised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

| Basic financial assets, including trade debtors, other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method. Financial assets classified as receivable within one year are not amortised.

| Financial liabilities and equity instruments are classified according to the substance of the contractual

| arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

| Basic financial liabilities, including trade creditors, other creditors, amounts owed to a group undertakings and directors loan accounts that are classified as debt, are initially recognised at transaction price unless the

| arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

| Financial liabilities are derecognsied when, and only when, the company's contractual obligations are discharged, cancelled, or they expire.

| Derivative financial instruments are recognsied at fair value using a valuation technique with any gains or losses being reported in profit or loss. Outstanding derivatives at reporting date are included under the appropriate format heading depending on the nature of the derivative.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Foreign currencies

| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

LHM MEDICAL TECHNOLOGY (UK) LIMITED (REGISTERED NUMBER: 12821991)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 MARCH 2026

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was NIL (2025 - 1 ).

4. | TANGIBLE FIXED ASSETS

| Computer

| equipment

£ |

| COST

| At 1 April 2025

| and 31 March 2026 | 12,536 |  |

| DEPRECIATION

| At 1 April 2025 | 10,968 |  |

| Charge for year | 1,568 |  |

| At 31 March 2026 | 12,536 |  |

| NET BOOK VALUE

| At 31 March 2026 | - |  |

| At 31 March 2025 | 1,568 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2026 | 2025 |

| (Unaudited)

£ | £ |

| Trade debtors | 360 |  | 809 |  |

| Other debtors | 193 |  | 139 |  |

553 |  | 948 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2026 | 2025 |

| (Unaudited)

£ | £ |

| Trade creditors | 91 |  | 168 |  |

| Amounts owed to group undertakings | 1,163,704 |  | 1,219,725 |  |

| Taxation and social security | 378 |  | 286 |  |

| Other creditors | 4,350 |  | 2,000 |  |

1,168,523 |  | 1,222,179 |  |

7. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

| The Report of the Auditors was unqualified.

| Thomas Smart (Senior Statutory Auditor)

| for and on behalf of Harold Sharp Limited

LHM MEDICAL TECHNOLOGY (UK) LIMITED (REGISTERED NUMBER: 12821991)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 MARCH 2026

7. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 - continued

| The Report of the Auditors was unqualified with a material uncertainty relating to going concern.

| We draw attention to Note 9 in the financial statements, which indicates that the company incurred a loss of £90,454 during the year ended 31 March 2026 and, as at that date, had net liabilities of £1,158,970. As stated in Note 9, the company's ability to continue as a going concern is dependent upon the continued financial support of its parent company.

| These events and conditions, along with the other matters described in Note 9, indicate the existence of a material uncertainty that may cast significant doubt on the company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.

8. | RELATED PARTY DISCLOSURES

| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

| The company's immediate parent company is LHM Medical Instruments Group Limited (2566472), a company incorporated and registered in Hong Kong.

| The smallest and largest group of which the company is a member and for which consolidated financial

| statements are prepared is LHM Holdings Limited (72518), a company incorporated and registered in Samoa.

9. | GOING CONCERN

| The company incurred a loss for the year of £90,454 (2025: £47,714) and, as at 31 March 2026, had net liabilities of £1,158,970 (2025: £1,068,516). The company is dependent upon the continued financial support of its parent company in order to meet its liabilities as they fall due. Amounts owed to group undertakings at 31 March 2026 amounted to £1,163,704 (2025: £1,219,725).

| The company's ability to continue as a going concern remains dependent upon the continued financial support of the parent company. Whilst the directors have received confirmation of such support, the company's reliance on that support represents a material uncertainty that may cast significant doubt on the company's ability to continue as a going concern. Should that support not be available, the company may be unable to meet its liabilities as they fall due.

| The financial statements have been prepared on a going concern basis and do not include any adjustments that would be necessary if the company were not a going concern. Having considered the financial support available from the parent, the directors remain satisfied that the preparation of the financial statements on a going concern basis is appropriate.